This raises the question of how, and in which cell type, synergy between CEBPA and GATA2 mutations is achieved, and in particular whether the bilineage leukemia phenotype is maintained by a single bipotent, or by two distinct lineage-restricted, leukemia-propagating cell populations. The gene discussed is GATA2; the disease is leukemia.